您现在的位置是:风核传媒 > 探索
Weight regain happens 4x faster after stopping GLP
风核传媒2026-01-31 21:53:21【探索】4人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(8)
上一篇: 领先技术 在水处理行业双剑出击
站长推荐
友情链接
- 炉石传说2024最强卡组推荐 炉石传说卡组排行
- 甄子丹回应带辛芷蕾入行:终究是靠她自己
- 如鸢彭城据点重建路线是什么 彭城据点重建路线一览
- สภาพอากาศกรุงเทพฯ 5 โมงเย็น ไม่มีฝน อุณหภูมิ 31 องศาฯ
- 大受热捧!南京建成多个智能垃圾分类示范点
- 非氪金玩家也可变土豪《醉武侠》可得元宝
- 社区“新宠”——智能垃圾分类桶
- Kỳ 115: Cà phê, nền tảng phát triển toàn diện của Costa Rica
- 2017九球中国公开赛录像 付小芳VS陈佳桦九球比赛视频
- 吴川青年加冕燃动南粤 省超十年蝶变照见南派足球振兴新篇
- VITURE Luma系列XR眼镜国内上市 AR眼镜进入手势操控时代
- 苹果iOS 26.2 Beta1上线:日版开放侧载
- 女子几近崩溃:卫生间装百叶窗,像裸奔了3年!很多上海人家也有
- 英特尔与印度达成合作 探索芯片制造与封装测试本地化
- 瑞达普®在华获批,一年四次给药降低80%甘油三酯水平与急性胰腺炎发生风险
- 新三国志曹操传无双甘宁技能介绍
- 经典版QQ回归!腾讯张军回应:偏好有时候是一种轮回
- 何小鹏:Robotaxi还是需要方向盘和刹车
- 《年夜武侠物语》设珍珑棋局 可否牵手胡年
- 语文在线直播老师征集令






